REG - Dr. Martens PLC - Director/PDMR Shareholding

Dr MartensAnnouncement

17/06/2025 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250617:nRSQ1781Na&default-theme=true

RNS Number : 1781N  Dr. Martens PLC  17 June 2025

Dr. Martens plc (the 'Company')

Director / PDMR Shareholding

Notification of Transactions by Directors / Persons Discharging Managerial
Responsibility

The Company announces that on 16 June 2025 the following directors / persons
discharging managerial responsibility ('PDMR') were granted Performance Share
Awards (the 'Awards') under the Company's Long Term Incentive Plan (the
'LTIP').

 

 PDMR          Number of Shares
 Ije Nwokorie  2,628,032
 Giles Wilson  2,019,743

 

As disclosed in the Company's 2025 Annual Report, the Awards will vest subject
to the achievement of three equally weighted targets, namely cumulative
earnings per share, relative total shareholder return and operating cash flow
conversion, over three years. On vesting, the Awards will be subject to a
further two-year holding period. No consideration was paid for the grant of
the Award and no price is payable on the exercise of the Award.

Full details of the target ranges are set out in the Directors' Remuneration
Report contained within the 2025 Annual Report & Accounts, which is
available on the Company's website at www.drmartensplc.com
(http://www.drmartensplc.com) .

The relevant notifications set out below are provided in accordance with the
requirements of Article 19 of the UK Market Abuse Regulation.

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Ije Nwokorie
 2   Reason for the notification
 a)  Position/status                                              PDMR (Chief Executive Officer)
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Dr. Martens plc
 b)  LEI                                                          213800QPT8YM6NQZPH28
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of GBP 0.01

     Identification code                                          ISIN: GB00BL6NGV24
 b)  Nature of the transaction                                    Grant of performance share award under the Dr. Martens Long Term Incentive
                                                                  Plan
 c)  Price(s) and volume(s)                                           Price(s)  Volume(s)
                                                                    Nil       2,628,032
 d)  Aggregated information

- Aggregated volume

     - Price                                                      2,628,032

                                                            Nil

 
 e)  Date of the transaction                                      16 June 2025
 f)  Place of the transaction                                     Outside of a trading venue

d)

Aggregated information

 -  Aggregated volume
 -  Price

 

 

2,628,032

Nil

e)

Date of the transaction

16 June 2025

f)

Place of the transaction

Outside of a trading venue

 

 

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Giles Wilson
 2   Reason for the notification
 a)  Position/status                                              PDMR (Chief Financial Officer)
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Dr. Martens plc
 b)  LEI                                                          213800QPT8YM6NQZPH28
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of GBP 0.01

     Identification code                                          ISIN: GB00BL6NGV24
 b)  Nature of the transaction                                    Grant of performance share award under the Dr. Martens Long Term Incentive
                                                                  Plan
 c)  Price(s) and volume(s)                                           Price(s)  Volume(s)
                                                                    Nil       2,019,743
 d)  Aggregated information

- Aggregated volume

     - Price                                                      2,019,743

                                                            Nil

 
 e)  Date of the transaction                                      16 June 2025
 f)  Place of the transaction                                     Outside of a trading venue

d)

Aggregated information

 -  Aggregated volume
 -  Price

 

 

2,019,743

Nil

e)

Date of the transaction

16 June 2025

f)

Place of the transaction

Outside of a trading venue

 

For further information, please contact:

Paul Rolling, Head of Secretariat

+447584243562

Bethany Barnes, Director of Investor Relations

+447825187465

ENDS

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global
presence. "Docs" or "DMs" were originally produced for their durability for
workers, before being adopted by diverse youth subcultures and associated
musical movements. Today, Dr. Martens has transcended its roots while still
celebrating its proud history. It operates in over 60 countries and employs
over 3,650 people worldwide. Its operations are split across both
Direct-to-Consumer and wholesale channels, and in addition to its
world-renowned "1460" boot its product segments span shoes including the 1461
shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as
well as a growing line of bags and accessories. Further information can be
found at https://www.drmartensplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUBVWRVVUNARR